- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01837147
Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)
February 5, 2020 updated by: University of California, San Diego
Using Technology to Promote Activity in Women at Elevated Breast Cancer Risk
Women who are overweight or do not exercise are at higher risk for breast cancer after menopause.
This study will test a new electronic device that measures the body's movement and works alongside a website to help women increase their physical activity level.
If effective, this system could be tested in larger studies aiming to reduce breast cancer risk by reducing or preventing obesity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
La Jolla, California, United States, 92093
- Moores UCSD Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female
- Postmenopausal
- BMI >= 25.0 kg/m2
- Physically inactive
- Internet user with regular access to high-speed internet
- Willing and able to complete study requirements
Exclusion Criteria:
- History of invasive breast cancer
- Medical contraindication to exercise
- Medical problem or other issue that would interfere with intervention
- Current participation in another physical activity study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Web-based Tracking Group
Technology-Based Physical Activity Promotion
|
Participants assigned to this group will use a web-integrated physical activity monitor, and accompanying website, to improve their physical activity levels.
|
|
Active Comparator: Pedometer Group
Participants assigned to this group will receive a pedometer.
|
Participants assigned to this group will receive a pedometer and be trained in its use.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in objectively-measured physical activity
Time Frame: Baseline to 16 weeks
|
Assessed using ActiGraph.
|
Baseline to 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported physical activity
Time Frame: Baseline to 16 weeks
|
Assessed using questionnaires.
|
Baseline to 16 weeks
|
|
Body weight (kg)
Time Frame: Baseline to 16 weeks
|
Measured in clinic.
|
Baseline to 16 weeks
|
|
Uptake of technology-based intervention components
Time Frame: During 16-week intervention
|
To be assessed via data downloaded from the website used in this study.
|
During 16-week intervention
|
|
Quality of life
Time Frame: Baseline to 16 weeks
|
To be assessed via self-report questionnaire.
|
Baseline to 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lisa A Cadmus-Bertram, PhD, University of California, San Diego
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Cadmus-Bertram L, Marcus BH, Patterson RE, Parker BA, Morey BL. Use of the Fitbit to Measure Adherence to a Physical Activity Intervention Among Overweight or Obese, Postmenopausal Women: Self-Monitoring Trajectory During 16 Weeks. JMIR Mhealth Uhealth. 2015 Nov 19;3(4):e96. doi: 10.2196/mhealth.4229.
- Cadmus-Bertram LA, Marcus BH, Patterson RE, Parker BA, Morey BL. Randomized Trial of a Fitbit-Based Physical Activity Intervention for Women. Am J Prev Med. 2015 Sep;49(3):414-8. doi: 10.1016/j.amepre.2015.01.020. Epub 2015 Jun 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2013
Primary Completion (Actual)
October 1, 2014
Study Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
April 6, 2013
First Submitted That Met QC Criteria
April 17, 2013
First Posted (Estimate)
April 23, 2013
Study Record Updates
Last Update Posted (Actual)
February 7, 2020
Last Update Submitted That Met QC Criteria
February 5, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R03CA168450-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Technology-Based Physical Activity Promotion
-
Pr Fabienne d'Arripe-LonguevilleCentre Hospitalier Universitaire de Nice; Association Azur Sport Santé, Nice...UnknownBariatric Surgery CandidateFrance
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
University of OklahomaTSET Health Promotion Research CenterRecruitingMetastatic Invasive Breast CancerUnited States
-
The Children's Hospital of Zhejiang University...Not yet recruitingCongenital Heart Disease | Physical InactivityChina
-
Northumbria UniversityNewcastle-upon-Tyne Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
UKK InstituteFinnish Institute of Occupational Health; Finnish Sports Confederation; Päijät-Hämeen... and other collaboratorsCompletedPhysical Activity | Sedentary Behavior | Work AbilityFinland
-
University of OklahomaRecruitingChemotherapy Side Effects | Cancer SurvivorshipUnited States
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedArthritis | Joint Diseases | Osteoarthritis | Osteoarthritis, Knee | Anterior Cruciate Ligament Injuries | Knee Injuries | Exercise | Cartilage, ArticularUnited States
-
University of PennsylvaniaRobert Wood Johnson FoundationCompleted
-
Medical College of WisconsinNational Cancer Institute (NCI)RecruitingCervical Cancer | Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Endometrial CancerUnited States